YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD. – Trademark Portfolio

Entity Type: 16

YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include GLAIVE, FOLANCE, and PISSILE.

Room 601, 6th Floor, No. 4 Lane 268 Linxin Road,

Changning District Shanghai

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MUSKET
MUSKET
Pending 2026
GLAIVE
GLAIVE
Registered 2025
PISSILE
PISSILE
Registered 2025
FOLANCE
FOLANCE
Registered 2025

Trademark Classifications

YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD. have?

YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending.

What trademark classes does YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD. file in?

YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD.'s most well-known trademarks?

YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD.'s registered trademark portfolio includes well-known marks such as GLAIVE, FOLANCE, and PISSILE. These are among 3 currently registered trademarks in the portfolio.

What is YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD.'s trademark registration success rate?

YIFAN BIOTECHNOLOGY (SHANGHAI) CO., LTD. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.